News

European Medical Journal12h
Updates in Advanced Hormone Receptor-Positive Breast Cancer: From Circulating Tumor DNA-Guided Therapy to Precision Medicine
The therapeutic landscape for hormone receptor-positive (HR+) advanced breast cancer (BC) is moving from generalized ...
European Medical Journal13h
Neoadjuvant Therapy in Triple-Negative Breast Cancer: Current Landscape and Emerging Therapies
Triple-negative breast cancer (TNBC) comprises 10–15% of all breast cancers. It is a very heterogeneous disease, ...